SIRT2 and pancreatic ductal adenocarcinoma: We have shown that mice lacking Sirt2 develop tumors in multiple organs, including pancreatic ductal adenocarcinomas (PDAC)10, and interestingly, the combination of Sirt2 deletion with an oncogenic KrasG12D mutation induces PDAC at three months11.